Consensus Cellebrite DI Ltd.

Equities

CLBT

IL0011794802

Market Closed - Nasdaq 04:00:00 2024-05-24 pm EDT 5-day change 1st Jan Change
11.1 USD -6.57% Intraday chart for Cellebrite DI Ltd. -3.73% +28.18%

Evolution of the average Target Price on Cellebrite DI Ltd.

Price target over the last 5 years

History of analyst recommendation changes

10.QWiR6Eb1Bd2nAVl9QibGuqaj7o6MYy5Tt8F_cHNf_ZQ.bCPhjTeiPZHRZ2osJ2eT9ueSw-r6O1YjxbQSCgEZp-w0PqCQI6BV7_MxLg~d102d13058af8632c3b5680bf907c71c
JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating MT
Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating MT
Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target MT
BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating MT
Needham Adjusts Price Target on Cellebrite to $13.50 From $13, Keeps Buy Rating MT
William Blair Upgrades Cellebrite DI to Outperform From Market Perform MT
BofA Securities Upgrades Cellebrite to Buy From Neutral on Solid Q4 Earnings, Business Momentum, Raises PT to $12 From $9 MT
Deutsche Bank Raises Cellebrite DI Price Target to $13 From $10, Maintains Buy Rating MT
Deutsche Bank Adjusts Cellebrite DI Price Target to $9 From $6.50, Maintains Buy Rating MT
Needham Adjusts Price Target on Cellebrite DI to $10 From $7, Keeps Buy Rating MT
Craig-Hallum Starts Cellebrite DI at Buy With $11 Price Target MT
Needham Adjusts Cellebrite DI Price Target to $7 From $6.50, Maintains Buy Rating MT
Deutsche Bank Adjusts Cellebrite DI Price Target to $6.50 From $6, Maintains Buy Rating MT
Deutsche Bank Adjusts Cellebrite DI's Price Target to $6 From $7, Maintains Buy Rating MT
BofA Securities Downgrades Cellebrite DI to Neutral MT
Deutsche Bank Adjusts Cellebrite's Price Target to $7 From $10, Maintains Buy Rating MT
Cowen Adjusts Price Target on Cellebrite DI to $10 From $13, Keeps Outperform Rating MT
William Blair Downgrades Cellebrite DI to Market Perform From Outperform MT
Needham Adjusts Cellebrite DI's Price Target to $6 from $9.50, Keeps Buy Rating MT
JPMorgan Starts Cellebrite DI at Overweight With $10.50 Price Target MT
Deutsche Bank Adjusts Cellebrite DI's Price Target to $11 From $10.50, Maintains Buy Rating MT
Deutsche Bank Initiates Coverage on Cellebrite DI With Buy Rating, $10.50 Price Target MT
Needham Adjusts Price Target on Cellebrite DI to $9.50 From $12, Reiterates Buy Rating MT
BofA Securities Starts Cellebrite DI at Buy with $11 Price Target MT
CELLEBRITE DI : Citigroup Starts Cellebrite at Buy with $15 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
11.1 USD
Average target price
14.36 USD
Spread / Average Target
+29.34%
High Price Target
16 USD
Spread / Highest target
+44.14%
Low Price Target
13 USD
Spread / Lowest Target
+17.12%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cellebrite DI Ltd.

Deutsche Bank Securities
JPMorgan Chase
Lake Street
BofA Securities
Needham & Co.
William Blair & Co.
Craig-Hallum
Cowen
Citigroup
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
  1. Stock Market
  2. Equities
  3. CLBT Stock
  4. Consensus Cellebrite DI Ltd.